Retour
Fourchette du Jour
33,60 €
35,59 €
Fourchette 52 Semaines
20,85 €
54,85 €
Volume
511 271
Moyenne 50J / 200J
44,58 €
/
40,45 €
Clôture Précédente
34,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -255,0 | 0,3 |
| P/B | 25,0 | 2,9 |
| ROE % | -8,4 | 3,7 |
| Net Margin % | -1,9 | 3,8 |
| Rev Growth 5Y % | 39,2 | 10,0 |
| D/E | 4,8 | 0,2 |
Objectif de Cours des Analystes
Hold
74,25 €
+110.9%
Low: 63,00 €
High: 94,00 €
P/E Prévisionnel
46,7
BPA Prévisionnel
0,73 €
Croissance BPA (est.)
+0,0%
CA Est.
370 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,79 €
8,13 € – 9,96 €
|
1,1 B | 1 |
| FY2029 |
7,31 €
6,76 € – 8,28 €
|
970 M | 1 |
| FY2028 |
4,13 €
2,92 € – 5,34 €
|
740 M | 2 |
Points Clés
Revenue grew 39,22% annually over 5 years — strong growth
Debt/Equity of 4,80 — high leverage
Generating 42,98M in free cash flow
Capital efficient — spends only 0,33% of revenue on capex
Interest coverage of 1,51× — tight debt servicing
Croissance
Revenue Growth (5Y)
39,22%
Revenue (1Y)36,41%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-8,42%
ROIC8,97%
Net Margin-1,89%
Op. Margin13,37%
Sécurité
Debt / Equity
4,80
Current Ratio2,20
Interest Coverage1,51
Valorisation
P/E Ratio
-255,01
P/B Ratio24,99
EV/EBITDA40,92
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36,41% | Revenue Growth (3Y) | 44,62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 39,22% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 272,30M | Net Income (TTM) | -5,14M |
| ROE | -8,42% | ROA | -1,29% |
| Gross Margin | 75,05% | Operating Margin | 13,37% |
| Net Margin | -1,89% | Free Cash Flow (TTM) | 42,98M |
| ROIC | 8,97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4,80 | Current Ratio | 2,20 |
| Interest Coverage | 1,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -255,01 | P/B Ratio | 24,99 |
| P/S Ratio | 4,81 | PEG Ratio | 4,91 |
| EV/EBITDA | 40,92 | Dividend Yield | 0,00% |
| Market Cap | 1,31B | Enterprise Value | 1,49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 272,30M | 199,61M | 130,19M | 88,60M | 72,48M |
| Net Income | -5,14M | -17,48M | -24,41M | -14,09M | -18,01M |
| EPS (Diluted) | -0,14 | -0,49 | -0,75 | -0,51 | -0,69 |
| Gross Profit | 204,37M | 150,37M | 90,55M | 63,21M | 54,26M |
| Operating Income | 36,40M | 8,82M | 431 000,0 | 1,92M | 1,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 399,48M | 388,97M | 311,76M | 157,38M | 98,33M |
| Total Liabilities | 347,39M | 319,67M | 241,75M | 130,14M | 87,40M |
| Shareholders' Equity | 52,45M | 69,65M | 70,36M | 27,60M | 11,29M |
| Total Debt | 251,98M | 228,83M | 190,50M | 112,23M | 77,96M |
| Cash & Equivalents | 72,93M | 47,25M | 74,09M | 96,27M | 42,17M |
| Current Assets | 211,75M | 189,65M | 139,07M | 118,26M | 60,66M |
| Current Liabilities | 96,30M | 91,34M | 49,34M | 18,63M | 9,72M |